What does the evidence say about Matcha Anxiety Randomized Trial?

The current Migaku evidence database contains 3 reusable source documents for Matcha Anxiety Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - According to the Centers for Disease Control (CDC), the percentage of adults who received mental health treatment over the previous 12 months increased from 19.2% to 23.9% from 2019 to 2023 []. [Cavanah Aidan M. (2025); evidence level 1] - This has been proven to be somewhat problematic, as antidepressants have been found to be less useful in cases of mild to moderate depression, which constitutes the majority of individuals with depression []. [Cavanah Aidan M. (2025); evidence level 1] - EGCG has been found to bind to cell surface receptors like 67-kDa laminin receptor (anti-tumor) and toll-like receptor (anti-inflammatory) [], with other published studies reporting it has antioxidant, anticancer, antidiabetic, antimicrobial, and neuroprotective roles []. [Cavanah Aidan M. (2025); evidence level 1] - 1 2 3 4 5 6 Mood is defined as an internal, sustained feeling that impacts an individual’s behaviour, emotional state, and interaction with the external world []. [Cavanah Aidan M. (2025); evidence level 1] - Theanine, a major amino acid in green tea, exhibits a stress-reducing effect in mice and humans. [Unno K (2018); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.